SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-19-013390
Filing Date
2019-07-02
Accepted
2019-07-02 17:03:40
Documents
1
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 3192
  Complete submission text file 0001437749-19-013390.txt   4675
Mailing Address C/O SOMAXON PHARMACEUTICALS, INC. 10935 VISTA SORRENTO PARKWAY, SUITE 250 SAN DIEGO CA 92130
Business Address
Pascoe Richard W (Reporting) CIK: 0001343266 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36913 | Film No.: 19938613

Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
KEMPHARM, INC (Issuer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations